| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ASTHMA |
32 with reduced risk of childhood but not adult asthma
Department of Child Health, University of Aberdeen, Aberdeen AB25 2ZD, UK
Correspondence to:
Correspondence to:
Professor P J Helms, Department of Child Health, University of Aberdeen, Aberdeen AB25 2ZD, UK;
p.j.helms{at}abdn.ac.uk
Background: A number of potential candidate genes have been implicated in the pathogenesis of asthma. A 32 base pair deletion in the CCR5 gene renders this chemokine receptor non-functioning and has been shown to be associated with a reduced prevalence of asthma in childhood. The mechanism may be related to impairment of pathogen entry into cells and modified host inflammatory response. We sought to determine the influence of the CCR5
32 mutation on asthma and allergy in the transition from childhood to adulthood.
Methods: 627 individuals first studied as part of a whole population schoolchildren cohort in 1989 when aged 8–12 years were followed up 10 years later for respiratory and allergy symptoms and laboratory markers of atopy. CCR532 status was also characterised and the association with childhood and adulthood symptoms determined.
Results: The follow up sample was representative of the original cohort except for a slightly greater prevalence of symptomatic individuals. As children, none who were homozygous for the CCR532 mutation had a current physician’s diagnosis of asthma. In multivariate analysis and controlling for known confounders, the protective effect of carrying the allele in childhood was highly significant (OR 0.31, 95% CI 0.14 to 0.72, p=0.006). There was no protective association with "current asthma" as classified in adulthood within the same population. Subjective or laboratory markers of atopy in childhood or adulthood were not associated with the CCR532 mutation. Methacholine bronchial hyperresponsiveness in adulthood was also unrelated to gene carrier status.
Conclusions: In a population with a high allelic frequency for the CCR532 mutation, a significant protection against childhood asthma is evident which is independent of atopy. This protection is lost in the transition between childhood and early adulthood. The contribution of different genetic candidates to the expression of asthma may change with advancing maturity and confound the interpretation of association and linkage studies unless age is taken into account.
Keywords: asthma; children; genotype; phenotype; DNA polymorphism
Relevant Article
Thorax 2003 58: 189.
This article has been cited by other articles:
|
|
 |
|
  H. B. Rasmussen, S. Timm, A. G. Wang, K. Soeby, H. Lublin, M. Fenger, R. Hemmingsen, and T. Werge Association Between the CCR5 32-bp Deletion Allele and Late Onset of Schizophrenia Am J Psychiatry, March 1, 2006; 163(3): 507 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thakkinstian, M. McEvoy, C. Minelli, P. Gibson, B. Hancox, D. Duffy, J. Thompson, I. Hall, J. Kaufman, T.-f. Leung, et al. Systematic Review and Meta-Analysis of the Association between {beta}2-Adrenoceptor Polymorphisms and Asthma: A HuGE Review Am. J. Epidemiol., August 1, 2005; 162(3): 201 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. O'Donnell, B. G. Toelle, G. B. Marks, C. M. Hayden, I. A. Laing, J. K. Peat, J. Goldblatt, and P. N. Le Souef Age-specific Relationship between CD14 and Atopy in a Cohort Assessed from Age 8 to 25 Years Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 615 - 622. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
